glp-1 drugs mounjaro Could Weight Loss Also Treat or Prevent Chronic Diseases? is mounjaro a glp-1 drug

Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear

As cardiovascular risk remains high among adults with type 2 diabetes and excess weight, the timely evaluation of new therapies is a public health priority

For people who are sensitive to GI side effects, slower titration generally produces better tolerability

Funding The authors declare that financial support was received for the research and/or publication of this article

GLP-1RA Use Patterns and Discontinuation Rates The study included 201,136 incident sulfonylurea users and 132,551 incident GLP-1RA users, with a median follow-up of three years

[DOI] [PubMed] [Google Scholar] 85.Singh S, et al